NO20085332L - Duloksetinhydrogenklorid-formuleringer med forsinket frigivelse - Google Patents

Duloksetinhydrogenklorid-formuleringer med forsinket frigivelse

Info

Publication number
NO20085332L
NO20085332L NO20085332A NO20085332A NO20085332L NO 20085332 L NO20085332 L NO 20085332L NO 20085332 A NO20085332 A NO 20085332A NO 20085332 A NO20085332 A NO 20085332A NO 20085332 L NO20085332 L NO 20085332L
Authority
NO
Norway
Prior art keywords
hydrogen chloride
delayed release
duloxetine
chloride formulations
layer
Prior art date
Application number
NO20085332A
Other languages
English (en)
Inventor
Gershon Kolatkar
Erela Zisman
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20085332L publication Critical patent/NO20085332L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Abstract

Formuleringer med forsinket frigivelse av duloksetinhydrogenklorid og fremgangsmåter for fremstilling av slike er beskrevet. En foretrukket formulering innbefatter en inert kjerne, et legemiddellag omfattende duloksetinhydrogenklorid, et skillelag og et enterisk lag som omfatter minst én av metakrylsyrekopolymer og hydroksypropylmetylcelluloseftalat.
NO20085332A 2006-05-22 2008-12-19 Duloksetinhydrogenklorid-formuleringer med forsinket frigivelse NO20085332L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80284906P 2006-05-22 2006-05-22
PCT/US2007/012387 WO2007139886A2 (en) 2006-05-22 2007-05-22 Duloxetine hydrochloride delayed release formulations

Publications (1)

Publication Number Publication Date
NO20085332L true NO20085332L (no) 2008-12-19

Family

ID=38779216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085332A NO20085332L (no) 2006-05-22 2008-12-19 Duloksetinhydrogenklorid-formuleringer med forsinket frigivelse

Country Status (12)

Country Link
US (1) US20070292511A1 (no)
EP (1) EP1919467A2 (no)
JP (1) JP2009538315A (no)
KR (1) KR20090005237A (no)
CN (1) CN101448493A (no)
BR (1) BRPI0711606A2 (no)
CA (1) CA2651716A1 (no)
IL (1) IL194877A0 (no)
MX (1) MX2008014758A (no)
NO (1) NO20085332L (no)
RU (1) RU2008148547A (no)
WO (1) WO2007139886A2 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008020286A2 (en) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Pharmaceutical compositions of duloxetine
US20100172972A1 (en) * 2007-05-21 2010-07-08 Sun Pharmaceutical Industries Limited Enteric coated pharmaceutical compositions
GB0712220D0 (en) * 2007-06-23 2007-08-01 Arrow Int Ltd Duloxetine formulation
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
US20090017113A1 (en) * 2007-07-13 2009-01-15 Osinga Niels J Duloxetine formulations
JP2011510024A (ja) * 2008-01-25 2011-03-31 アルファファーム ピーティーワイ リミテッド デュロキセチンの遅延放出医薬組成物
US20110020439A1 (en) * 2008-03-24 2011-01-27 Shrenik Annasaheb Kole Delayed release compositions of duloxetine
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
EA201001871A1 (ru) * 2008-06-13 2011-08-30 Крка, Д.Д. Ново Место Гастрорезистентные пероральные фармацевтические композиции, содержащие дулоксетин или его фармацевтически приемлемые производные
US20100040680A1 (en) * 2008-08-15 2010-02-18 Felix Lai Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
ES2376095B1 (es) * 2008-10-02 2013-01-24 Laboratorios Del Dr. Esteve, S.A. Pellets entéricos de duloxetina.
WO2010078878A1 (en) * 2009-01-12 2010-07-15 Synthon B.V. Duloxetine formulations
DE102009033621A1 (de) 2009-07-17 2011-01-20 Add Technologies Ltd. Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
CA2792523C (en) * 2010-03-09 2018-01-09 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
EP2377525A1 (en) 2010-03-26 2011-10-19 Laboratorios del Dr. Esteve S.A. Duloxetine enteric pellets
WO2013045352A1 (de) * 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
EP2916824B1 (en) 2012-11-12 2019-06-19 New Jersey Institute of Technology Pharmaceutical core-shell composite powder and processes for making the same
CN103127023B (zh) * 2013-03-01 2014-08-27 河北天成药业股份有限公司 一种盐酸度洛西汀肠溶片及其制备方法
CN103211777A (zh) * 2013-03-31 2013-07-24 北京万全阳光医学技术有限公司 一种盐酸度洛西汀的药物制剂及其制备的方法
CN103393615B (zh) * 2013-07-24 2015-07-15 海南华益泰康药业有限公司 一种度洛西汀肠溶小丸及其制备方法
PL224543B1 (pl) 2013-08-21 2017-01-31 Pabianickie Zakłady Farm Polfa Spółka Akcyjna Dojelitowa tabletka duloksetyny
JP6815109B2 (ja) * 2016-06-23 2021-01-20 キョーリンリメディオ株式会社 デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物
JP6866136B2 (ja) * 2016-11-30 2021-04-28 共和薬品工業株式会社 デュロキセチン塩酸塩を含む口腔内崩壊錠
US9839626B1 (en) 2016-12-14 2017-12-12 Sun Pharmaceutical Industries Limited Duloxetine sprinkles
JP2018154590A (ja) * 2017-03-17 2018-10-04 沢井製薬株式会社 デュロキセチン腸溶性顆粒およびデュロキセチン腸溶性製剤
JP7072431B2 (ja) * 2017-04-14 2022-05-20 富士化学工業株式会社 錠剤及びその製造方法
JP6972674B2 (ja) * 2017-06-06 2021-11-24 ニプロ株式会社 経口医薬製剤
JP2019081753A (ja) * 2017-10-30 2019-05-30 大原薬品工業株式会社 デュロキセチン塩酸塩の溶出性が改善された腸溶性製剤
WO2019157066A1 (en) * 2018-02-06 2019-08-15 Robert Niichel A multiparticulate including pharmaceutical or probiotic active ingredients
CN112566668A (zh) * 2018-06-22 2021-03-26 快力胶囊股份有限公司 肠溶性硬胶囊
JP2020029447A (ja) * 2018-06-25 2020-02-27 大原薬品工業株式会社 腸溶性高分子及び抗付着剤を含有する顆粒
PL3628311T3 (pl) * 2018-09-27 2021-07-05 Inibsa Ginecologia, S.A. Sposób wytwarzania doustnej wielojednostkowej postaci dawkowanej bursztynianu doksylaminy i chlorowodorku pirydoksyny o zmodyfikowanym uwalnianiu
CN112168797A (zh) * 2020-10-14 2021-01-05 宁波高新区美诺华医药创新研究院有限公司 度洛西汀药物组合物
WO2022115054A1 (en) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Enteric coated duloxetine compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
EP1699458A4 (en) * 2003-12-30 2012-04-25 Reddys Lab Ltd Dr PHARMACEUTICAL COMPOSITION
GB0410470D0 (en) * 2004-05-11 2004-06-16 Cipla Ltd Pharmaceutical compound and polymorphs thereof
JP2008543929A (ja) * 2005-06-20 2008-12-04 カディラ・ヘルスケア・リミテッド デュロキセチンの調節放出型の投与製剤
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions

Also Published As

Publication number Publication date
MX2008014758A (es) 2009-01-19
EP1919467A2 (en) 2008-05-14
CN101448493A (zh) 2009-06-03
RU2008148547A (ru) 2010-06-27
BRPI0711606A2 (pt) 2012-02-14
KR20090005237A (ko) 2009-01-12
WO2007139886A2 (en) 2007-12-06
US20070292511A1 (en) 2007-12-20
CA2651716A1 (en) 2007-12-06
JP2009538315A (ja) 2009-11-05
WO2007139886A3 (en) 2008-03-13
IL194877A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
NO20085332L (no) Duloksetinhydrogenklorid-formuleringer med forsinket frigivelse
NO20076288L (no) Farmasoytiske sammensetninger innbefattende imatinib og et frigivningssinkende middel
EA201892836A1 (ru) Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
DK2032123T3 (da) Anvendelse af en hydrofil matrix indeholdende et polyacrylsurederivat, en celluloseether og en disintegrant til fremstilling af et medikament til behandling af kvindelige kønslidelser
SI1830855T1 (sl) Trdne oralno aplikabilne farmacevtske dajalne oblike z modificiranim sproščanjem ki vsebujejo rivaroksaban
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
AU2008347158A8 (en) Oral pharmaceutical dosage forms
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
DK1940364T4 (da) Kapselformulering af pirfenidon og farmaceutisk acceptable excipienser
ATE457719T2 (de) Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
DK1940366T3 (da) Blöde kapsler, der omfatter palonosetron-hydrochlorid, som har forbedret stabilitet og biotilgængelighed
WO2009058950A3 (en) Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
EP1796641A4 (en) NEW FORMULATION, OMEPRAZOL ANTAZIDA COMPLEX WITH IMMEDIATE RELEASE FOR THE RAPID AND CONTINUOUS SUPPRESSION OF MAGIC ACID
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
NO20071175L (no) Sammensetning for langvarig medikamentfrigivning som viser et okende null-bestillende frigivningsmonster, fremgangsmate for fremstilling av en slik sammensetning
WO2009043926A3 (en) Oral fast disintegrating tablets
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20091299L (no) Substituerte sulfonamidderivater
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
WO2009090484A3 (en) Mesalazine tablet
DK1711169T3 (da) Coatede mikrodepottabletter med venlafaxinhydrochlorid
IL186000A0 (en) Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application